Postoperative pain in patients undergoing oral tumor surgery
Conditions
Interventions
Morphine hydrochloride Group:Postoperative continuous intravenous analgesia with Morphine hydrochloride
Tegileridine Group:Postoperative continuous intravenous analgesia with Tegileridine
Sponsors
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged >= 18 and == 60 mL/min); 4. Sign the informed consent form and voluntarily participate in the study.
Exclusion criteria
Exclusion criteria: 1. Patients who have been administered opioids or other analgesic medications before surgery; 2. Patients requiring mechanical ventilation or ICU monitoring after surgery; 3. Patients who having severe cardiovascular or respiratory diseases, or a history of drug abuse; 4. Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The resting summed pain intensity difference over 24 hours (rSPID24).; | — |
Secondary
| Measure | Time frame |
|---|---|
| Various vital signs (blood pressure, heart rate, respiratory rate, pulse oximetry, body temperature);SAEs;Quality of life and satisfaction; | — |
Countries
China
Contacts
Public ContactLi Jingjie
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Outcome results
None listed